New Results

Virus-like particle displaying SARS-CoV-2 receptor binding domain elicits neutralizing antibodies and is protective in a challenge model

Julia L. McKechnie, Brooke Fiala, Clancey Wolf, Daniel Ellis, Douglas Holtzman, Andrew Feldhaus
doi: https://doi.org/10.1101/2022.11.29.518404

Article Information

doi 
https://doi.org/10.1101/2022.11.29.518404
History 
  • November 29, 2022.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.

Author Information

  1. Julia L. McKechniea,#,*,
  2. Brooke Fialaa,*,
  3. Clancey Wolfa,
  4. Daniel Ellisa,
  5. Douglas Holtzmana and
  6. Andrew Feldhausa
  1. aIcosavax, Inc., 1930 Boren Ave, Suite 1000, Seattle, WA 98101, USA
  1. ↵# Corresponding author; email: julia.mckechnie{at}icosavax.com

  1. ↵* These authors have contributed equally to this work

Back to top
Posted November 29, 2022.
Download PDF

Supplementary Material

Email
Virus-like particle displaying SARS-CoV-2 receptor binding domain elicits neutralizing antibodies and is protective in a challenge model
Julia L. McKechnie, Brooke Fiala, Clancey Wolf, Daniel Ellis, Douglas Holtzman, Andrew Feldhaus
bioRxiv 2022.11.29.518404; doi: https://doi.org/10.1101/2022.11.29.518404
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area